Brain stimulation for COVID-19 recovery
Part of Infections, Lungs & breathing clinical trials.
This trial tests a gentle brain stimulation method called tDCS to help people recover after COVID-19 infection. If you are an adult who recently had COVID-19 and is now testing negative, this study might help improve lingering symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You tested positive for COVID-19 in the last 60 days and now test negative.
- You are between 18 and 50 years old.
- At least 21 days have passed since your COVID-19 symptoms started.
- You do not have any brain, nerve, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how COVID-19 affects thinking and memory. It aims to understand and help people who still have brain fog or other cognitive issues after their infection.
This study tests whether a gentle, non-invasive brain stimulation technique (transcranial direct current stimulation) can help relieve brain fog and fatigue in people with long COVID. If you qualify, you would receive several sessions of the stimulation over a few weeks.
This study tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help people aged 18 to 65 who have ongoing depression or low mood for more than 12 weeks after a confirmed COVID-19 infection. The treatment uses magnetic pulses to gently stimulate parts of the brain involved in mood regulation.
This trial tests if a gentle brain stimulation technique called tDCS can help improve memory and thinking in people who have had a stroke. It is for those who are still in the early recovery phase (between 10 days and 5 months after their stroke) and have some ongoing cognitive problems.
This study looks at whether brain stimulation and brain scans can help measure recovery after an ischemic stroke. It may help researchers understand who benefits from non-invasive brain stimulation by using brain “signal” markers.
This trial tests a safe, non-invasive brain stimulation technique called tDCS to help people recover from a recent stroke. It's for people who cannot have the standard clot-removal procedure and who can start treatment within 24 hours of their stroke.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.